Citius Pharmaceuticals, Inc. (CTXR) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CTXR Hot Sheet
Join SI Premium – FREE
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Citius Pharmaceuticals, Inc. (CTXR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker
- Taylor Devices (TAYD) Misses Q4 EPS by 31c
- How 3BL's AI Visibility Tracker Grades Sentiment
Create E-mail Alert Related Categories
EarningsRelated Entities
Citi, Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
